Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Raw Materials: 2019-2025

Historic Raw Materials for CorMedix (CRMD) over the last 2 years, with Sep 2025 value amounting to $7.0 million.

  • CorMedix's Raw Materials rose 1062.75% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 1062.75%. This contributed to the annual value of $1.1 million for FY2024, which is N/A change from last year.
  • CorMedix's Raw Materials amounted to $7.0 million in Q3 2025, which was up 530.68% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Raw Materials registered a high of $7.0 million during Q3 2025, and its lowest value of $603,545 during Q3 2024.
  • In the last 2 years, CorMedix's Raw Materials had a median value of $1.1 million in 2024 and averaged $1.9 million.
  • Over the last 5 years, CorMedix's Raw Materials had its largest YoY gain of 1,062.75% in 2025, and its largest YoY loss of 22.04% in 2025.
  • Over the past 2 years, CorMedix's Raw Materials (Quarterly) stood at $1.1 million in 2024, then spiked by 1,062.75% to $7.0 million in 2025.
  • Its Raw Materials was $7.0 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.